Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzastaurin Maintenance in Metastatic Colorectal Cancer
NCT00612586Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of enzastaurin in metastatic colorectal cancer (mCRC), sponsored by Eli Lilly and Company. Started Feb 2008; status: completed.
02
Drugs
enzastaurin
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00612586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00612586.